Prosecution Insights
Last updated: May 29, 2026

Examiner: STIMPERT, PHILIP EARL

Tech Center 3700 • Art Units: 1723 1789 3746 3783

This examiner grants 63% of resolved cases

Performance Statistics

62.7%
Allow Rate
-7.3% vs TC avg
947
Total Applications
+49.4%
Interview Lift
1292
Avg Prosecution Days
Based on 867 resolved cases, 2023–2026

Rejection Statute Breakdown

0.2%
§101 Eligibility
14.7%
§102 Novelty
71.1%
§103 Obviousness
12.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18197962 Delivery Device Systems, Methods, and Apparatuses Non-Final OA DEKA Products Limited Partnership
18087058 Delivery Device Apparatuses, Systems, and Methods Final Rejection DEKA Products Limited Partnership
17871345 SYSTEMS AND METHODS FOR FLUID DELIVERY Non-Final OA DEKA Products Limited Partnership
17899363 TECHNIQUE FOR SUPPRESSING MOTOR FAILURE IN BLOWER Final Rejection MAKITA CORPORATION
18112455 MEDICAL BALLOON SENSING ASSEMBLY AND METHOD Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18196022 CATHETER SECUREMENT DEVICE Final Rejection ABIOMED, Inc.
18060173 CATHETER AND TREATMENT METHOD Final Rejection TERUMO KABUSHIKI KAISHA
18091149 WOUND DEBRIDEMENT BY IRRIGATION WITH ULTRASONICALLY ACTIVATED MICROBUBBLES Non-Final OA Solventum Intellectual Properties Company
17936231 INSERTION DEVICE Final Rejection MEDTRONIC MINIMED, INC.
18232084 CATHETER WITH RAPID EXCHANGE GUIDEWIRE PORT AND METHOD OF MANUFACTURE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
17992096 INJECTABLE MATERIALS DELIVERY DEVICES, SYSTEMS, AND METHODS Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
17988192 INTRODUCER WITH SALINE ANTECHAMBER Non-Final OA Boston Scientific Scimed, Inc.
17920878 MINIATURIZED MEDICAL DEVICE HAVING A WAKE-UP DEVICE Non-Final OA BIOTRONIK SE & Co. KG
17923209 SYSTEM AND METHOD FOR ASYNCHRONOUS COMMUNICATION OF INFUSION INFORMATION AND OBTAINING REMOTE ASSISTANCE FOR AN ONGOING INFUSION Final Rejection CareFusion 303, Inc.
17944113 SYSTEM AND METHOD FOR DETECTING A LEAKING OCCLUDER VALVE Non-Final OA CareFusion 303, Inc.
18283626 DUAL PIEZOELECTRIC STACK PLUNGER SUB-ASSEMBLY Non-Final OA BECTON, DICKINSON AND COMPANY
18092583 Vascular Access System with Secondary Catheter Final Rejection Becton, Dickinson and Company
18416958 Combination Connector and System for Enteral Feeding Non-Final OA Avent, Inc.
17735719 Handheld Closed-Loop Automatic Insulin Delivery System Non-Final OA THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
18298580 Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations Non-Final OA Janssen Pharmaceutica NV
18080931 APPARATUS AND METHODS FOR MEDICAL APPLICATIONS OF LASER-DRIVEN MICROFUILD PUMPS Final Rejection University of Houston System
17988041 FUNCTIONAL POWDER DELIVERY DEVICE AND SYSTEM THEREOF Non-Final OA NATIONAL CHENG KUNG UNIVERSITY
17695375 An Electromagnetically-Actuated Rim Driven Hubless Fan with a Single Stage and Non-Magnetic Bearings Non-Final OA EMBRAER S.A.
17994879 DRAINAGE CATHETERS WITH LOCKING HUBS CONFIGURED FOR ONE-HANDED PIGTAIL LOCKING OPERATIONS Non-Final OA Bard Peripheral Vascular, Inc.
18126300 PUMPING ARRANGEMENT Non-Final OA Sulzer Management AG
18789138 Composite Safety Self-Destructing Injection Syringe Final Rejection Guangdong Hongshan Medical Device Technology Co., Ltd.
18196249 MULTIPLE TUBE INTRAVENOUS FLUID DELIVERY SYSTEM Non-Final OA Dukal, LLC
17783223 DEVICE FOR DELIVERING MEDICATION INCLUDING INTERPOSER Final Rejection AITA BIO INC.
18010992 PACKAGES COMPRISING ANTI-MICROBIAL COATINGS FOR PREVENTING CONTAMINATION, E.G. AFTER FIRST USE OF THE PRODUCT Final Rejection SIO2 MEDICAL PRODUCTS, INC.
18489725 RECTAL CATHETER WITH FLUID RESERVOIR AND METHOD FOR MANUFACTURING SAID RECTAL CATHETER Non-Final OA WELLSPECT AB

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month